文献速递眼底病与葡萄膜炎

Best病中的浆液性黄斑脱离:一种伪装综合征

SEROUS MACULAR DETACHMENT IN BEST DISEASE: A Masquerade Syndrome.
PubMed 文献 · Retina · 2020-01-01

本文描述了一组由Best病(BD)引起的浆液性黄斑脱离(SMD)病例,这些病例被误诊为新生血管性年龄相关性黄斑变性或中心性浆液性脉络膜视网膜病变,并接受了不适当的玻璃体内抗血管内皮生长因子或激光治疗。研究还提供了支持BD患者年龄相关脉络膜增厚的数据,这可能在该人群SMD的发生中起作用。

要点

  • 对于表现为SMD和难治性视网膜下液、模拟新生血管性AMD或慢性CSCR的患者,应考虑BD的诊断,以避免不必要的治疗。
  • BD患者黄斑中心凹下脉络膜厚度与年龄呈正相关,可能参与SMD的发病。
  • 识别BD相关SMD的多模态影像特征有助于准确诊断BD并减少不必要的眼内操作风险。

核心结论

  • 对于表现为SMD和难治性视网膜下液、模拟新生血管性AMD或慢性CSCR的患者,应考虑BD的诊断,以避免不必要的治疗操作。
  • BD患者黄斑中心凹下脉络膜厚度与年龄的正相关可能是该人群SMD发病和发展的一个因素。
  • 识别本研究详细描述的BD相关SMD的多模态影像特征将指导从业者准确诊断BD,并降低因不必要的眼内操作而带来潜在并发症的风险。

研究设计与样本

  • 本研究回顾并分析了临床检查和多模态影像学表现,包括彩色眼底照相、频域光学相干断层扫描、眼底自发荧光、荧光素血管造影和光学相干断层扫描血管成像。
  • 研究正式测量了黄斑中心凹下脉络膜厚度,并进行了年龄相关脉络膜厚度分析,与正常人群进行比较。
  • 共纳入13例患者(5例女性)的26只眼,中位年龄44岁。

主要发现

  • 9例患者有SMD病史和视网膜下液,对多种治疗(包括玻璃体内抗VEGF注射和光动力疗法)难治。
  • 6例患者通过基因检测诊断为BD,7例通过详细家族史诊断为BD。
  • 全部26只眼末次随访时平均logMAR最佳矫正视力为+0.36(Snellen等效为20/46)。
  • 在本队列中,黄斑中心凹下脉络膜厚度与年龄呈正相关,以每十年25.6 µm的速率线性增加(R=0.64;P<0.001)。
  • 光学相干断层扫描血管成像在4只眼中发现脉络膜新生血管,但这些眼对抗VEGF治疗无反应。

临床怎么用

  • 作者认为,对于表现为SMD和难治性视网膜下液、模拟新生血管性AMD或慢性CSCR的患者,应考虑BD的诊断,以避免不必要的治疗操作。
  • 作者认为,识别本研究详细描述的BD相关SMD的多模态影像特征将指导从业者准确诊断BD,并降低因不必要的眼内操作而带来潜在并发症的风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To describe the clinical and multimodal imaging findings of a series of cases of serous macular detachment (SMD) caused by Best disease (BD) masquerading as neovascular age-related macular degeneration or central serous chorioretinopathy that were inappropriately treated with intravitreal anti-vascular endothelial growth factor or laser therapy. This study will also present data to support age-related progressive choroidal thickening in BD patients, which may play a role in the development of SMD in this population. METHODS: Clinical examination and multimodal imaging findings, including color fundus photography, spectral-domain optical coherence tomography, fundus autofluorescence, fluorescein angiography, and optical coherence tomography-angiography, were reviewed and analyzed. Subfoveal choroidal thickness was also formally measured, and an age-related choroidal thickness analysis was performed and compared with a normal population. RESULTS: Twenty-six eyes of 13 patients (5 women) were included. Median age was 44 years. Nine patients presented with a history of SMD and subretinal fluid recalcitrant to various therapies, including intravitreal anti-vascular endothelial growth factor injections and photodynamic therapy. Best disease was subsequently diagnosed genetically in six patients and by detailed family history in seven. Mean logarithm of the minimum angle of resolution best-corrected visual acuity for all 26 eyes at last follow-up was +0.36 (Snellen equivalent of 20/46). Subfoveal choroidal thickness positively correlated with age for our cohort, increasing linearly at a rate of 25.6 µm per decade (R = 0.64; P < 0.001). Choroidal neovascularization was identified in four eyes on optical coherence tomography angiography, but these eyes did not respond to anti-vascular endothelial growth factor treatment. CONCLUSION: The diagnosis of BD should be considered in patients presenting with SMD and recalcitrant subretinal fluid masquerading as neovascular age-related macular degeneration or chronic central serous chorioretinopathy to avoid unnecessary treatment procedures. The positive correlation of subfoveal choroidal thickness with age in BD patients may be a factor in the pathogenesis and development of SMD in this population. Recognizing the multimodal imaging features of SMD associated with BD, described in detail in this study, will guide practitioners to the accurate diagnosis of BD and reduce the risk of unnecessary intraocular procedures with potential complications.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Zatreanu L, Freund KB, Leong BCS, et al. SEROUS MACULAR DETACHMENT IN BEST DISEASE: A Masquerade Syndrome. Retina. 2020. PMID: 31613838. doi:10.1097/IAE.0000000000002659

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。